139 related articles for article (PubMed ID: 11724313)
1. Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice.
Matsubara H; Gunji Y; Maeda T; Tasaki K; Koide Y; Asano T; Ochiai T; Sakiyama S; Tagawa M
Anticancer Res; 2001; 21(4A):2501-3. PubMed ID: 11724313
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
Chi CH; Wang YS; Lai YS; Chi KH
Anticancer Res; 2003; 23(1A):315-21. PubMed ID: 12680230
[TBL] [Abstract][Full Text] [Related]
3. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
[TBL] [Abstract][Full Text] [Related]
4. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
Wang L; Qi X; Sun Y; Liang L; Ju D
Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
[TBL] [Abstract][Full Text] [Related]
6. [Progress of gene therapy for esophageal cancer in Japan].
Matsubara H; Ochiai T
Gan To Kagaku Ryoho; 2003 Jul; 30(7):944-9. PubMed ID: 12894708
[TBL] [Abstract][Full Text] [Related]
7. [Study on the effects of combined IL-12 and GM-CSF gene therapy for murine liver cancer].
Qiu S; Ye S; Wang Z; Tang Z; Lu L; Xiao X
Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):413-6. PubMed ID: 12502439
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice.
Shan B; Yu L; Shimozato O; Li Q; Tagawa M
Anticancer Res; 2004; 24(1):79-82. PubMed ID: 15015579
[TBL] [Abstract][Full Text] [Related]
9. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
10. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection.
Liu X; Tian P; Yu Y; Yao M; Cao X; Gu J
Cancer Gene Ther; 2002 Jan; 9(1):100-8. PubMed ID: 11916239
[TBL] [Abstract][Full Text] [Related]
12. Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response.
Lee SG; Heo DS; Yoon SJ; Jee YS; Kang JO; Kim K; Kim CD; Sung MW; Kim NK
Anticancer Res; 2000; 20(4):2681-6. PubMed ID: 10953343
[TBL] [Abstract][Full Text] [Related]
13. Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors.
Collins CG; Tangney M; Larkin JO; Casey G; Whelan MC; Cashman J; Murphy J; Soden D; Vejda S; McKenna S; Kiely B; Collins JK; Barrett J; Aarons S; O'Sullivan GC
Cancer Gene Ther; 2006 Dec; 13(12):1061-71. PubMed ID: 16874363
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
15. [The protocol of clinical trial and basic experiments for esophageal cancer using gene transduction].
Matsubara H; Ochiai T
Nihon Rinsho; 2000 Sep; 58(9):1935-43. PubMed ID: 11004829
[TBL] [Abstract][Full Text] [Related]
16. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
17. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
[TBL] [Abstract][Full Text] [Related]
18. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy.
Chen Y; Chang KJ; Hwang LH; Chen CN; Tseng SH
Int J Colorectal Dis; 2002 Nov; 17(6):388-95. PubMed ID: 12355214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
